![JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies](https://www.mdpi.com/jcm/jcm-11-06254/article_deploy/html/images/jcm-11-06254-g001.png)
JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
![Tumor endothelial cells as a potential target of metronomic chemotherapy | Archives of Pharmacal Research Tumor endothelial cells as a potential target of metronomic chemotherapy | Archives of Pharmacal Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12272-018-01102-z/MediaObjects/12272_2018_1102_Fig1_HTML.png)
Tumor endothelial cells as a potential target of metronomic chemotherapy | Archives of Pharmacal Research
![Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer](https://www.cell.com/cms/attachment/436e6001-0579-4578-9f56-bf266bdf3b02/gr1_lrg.jpg)
Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer
![Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737217300269-gr1.jpg)
Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect
![Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis - Arrivi - 2022 - Journal of Neuroendocrinology - Wiley Online Library Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis - Arrivi - 2022 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/be543cd0-285d-40f5-b64b-68faad26ba2c/jne13189-toc-0001-m.jpg?trick=1704700976309)
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis - Arrivi - 2022 - Journal of Neuroendocrinology - Wiley Online Library
![Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health](https://www.thelancet.com/cms/attachment/e977474a-6e1f-4500-b5df-bcde846c02df/gr1.gif)
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health
![Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health](https://www.thelancet.com/cms/attachment/6562d315-2566-4490-900c-28bfd212ecbd/gr2_lrg.jpg)
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health
![Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. - Abstract - Europe PMC Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4666022/bin/nihms655024u1.jpg)
Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. - Abstract - Europe PMC
![Mechanisms of action of metronomic chemotherapy. The beneficial effects... | Download Scientific Diagram Mechanisms of action of metronomic chemotherapy. The beneficial effects... | Download Scientific Diagram](https://www.researchgate.net/publication/258036992/figure/fig1/AS:297351680937988@1447905573248/Mechanisms-of-action-of-metronomic-chemotherapy-The-beneficial-effects-of-metronomic.png)
Mechanisms of action of metronomic chemotherapy. The beneficial effects... | Download Scientific Diagram
![Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy - ScienceDirect Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365922001195-gr1.jpg)
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy - ScienceDirect
![Different mechanisms of action of a metronomic chemotherapy. (modified... | Download Scientific Diagram Different mechanisms of action of a metronomic chemotherapy. (modified... | Download Scientific Diagram](https://www.researchgate.net/publication/269781363/figure/fig2/AS:486208800333826@1492932619617/Different-mechanisms-of-action-of-a-metronomic-chemotherapy-modified-from-127.png)
Different mechanisms of action of a metronomic chemotherapy. (modified... | Download Scientific Diagram
![Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | Journal of Maxillofacial and Oral Surgery Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | Journal of Maxillofacial and Oral Surgery](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12663-023-01963-y/MediaObjects/12663_2023_1963_Fig2_HTML.png)
Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | Journal of Maxillofacial and Oral Surgery
![Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | springermedizin.de Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | springermedizin.de](https://media.springernature.com/lw345/springer-static/image/art%3A10.1007%2Fs12663-023-01963-y/MediaObjects/12663_2023_1963_Figa_HTML.png?as=jpg)